Every Child Connected Act This bill requires the Federal Communications Commission (FCC) to modify the E-rate program, which allots broadband discounts to schools and libraries. Specifically, the FCC must modify the program to (1) expand the eligible activities that qualify as being for educational purposes, (2) deem certain households in which students are participating in distance learning and are eligible for free or reduced-price school meals to be classrooms, and (3) provide that a school's eligibility shall not be diminished if it extends services obtained through the program to households with a child who is eligible for free or reduced-price school meals.
Advancing IoT for Precision Agriculture Act of 2021 This bill supports research and development for connected technologies that advance precision agriculture. In awarding grants under its sensor systems and networked systems programs, the National Science Foundation (NSF) shall consider certain research and development on sensor connectivity in environments of intermittent connectivity and intermittent computation. The NSF must prioritize applications that incorporate distance learning tools and approaches in awarding grants under the Advanced Technological Education Program to (1) junior or community colleges to develop or improve associate degree or certificate programs in an in-demand industry sector or occupation; or (2) institutions of higher education partnering with private sector employers, industry partnerships, or sector partnerships that commit to offering apprenticeships, internships, research opportunities, or applied learning experiences to enrolled students. The Government Accountability Office shall provide (1) a technology assessment of precision agriculture technologies; and (2) a review of federal programs that provide support for precision agriculture research, development, adoption, education, or training.
Toxic Exposure Training Act of 2021 This bill requires the Department of Veterans Affairs (VA) to provide training to its health care and benefits personnel regarding veterans who have been exposed to toxic substances. The VA must provide its health care personnel with education and training to identify, treat, and assess the impact of illnesses related to exposure to toxic substances. Such training must address how to ask for additional information from veterans regarding exposure to different toxicants. Additionally, the VA must establish an annual training program for claims processors who review claims for disability benefits related to service-connected disabilities based on exposure to toxic substances.
Combating Sexual Harassment in Science Act This bill addresses sexual harassment in the science, technology, engineering, and mathematics (STEM) fields by supporting research regarding sexual harassment and efforts to prevent and respond to sexual harassment. This bill directs the National Science Foundation (NSF) to award grants to institutions of higher education or nonprofit organizations (or their consortia) to expand research into the factors contributing to, and consequences of, sexual harassment affecting individuals in the STEM workforce, including students and trainees; and examine interventions for reducing the incidence and negative consequences of sexual harassment. The NSF must convene a working group to gather national data on the prevalence, nature, and implications of such harassment in institutions of higher education. The NSF shall enter into agreements with the National Academies of Sciences, Engineering, and Medicine to (1) update a responsible conduct guide issued by the National Academies to include, among other things, evidence-based practices for fostering a climate that is intolerant of sexual harassment; and (2) study the influence of sexual harassment in institutions of higher education on the career advancement of individuals in the STEM workforce. The National Science and Technology Council shall establish an interagency working group to coordinate the federal science agencies' efforts to reduce the prevalence of sexual harassment involving grant personnel. The Office of Science and Technology Policy must develop policy guidelines for such agencies to prevent and respond to reports of sexual harassment and gender harassment.
Restoring Neighborhoods and Strengthening Communities Act This bill directs the Department of Transportation (DOT) to establish a grant program to identify infrastructural barriers posed by transportation facilities within certain communities (e.g., communities of color, low-income communities, or tribal or indigenous populations) and study the feasibility of improving, and developing plans to improve, connectivity within these communities by redesigning or removing such barriers. DOT may award grants to states, tribal and local governments, nonprofit organizations, and other entities for (1) community engagement, education, and capacity building, including to educate community members about opportunities to affect transportation and economic development planning and investment decisions; and (2) planning and feasibility studies, including development of designs and artistic renderings to facilitate community engagement. It may also award capital construction grants to the owner of an infrastructural barrier to carry out projects for which all necessary feasibility studies and other planning activities have been completed, including the replacement of an infrastructural barrier with a new use or facility that has been identified by members of the community.
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021 This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit. Specifically, the bill requires PDP formularies to include covered generic drugs and biosimilars for which the wholesale acquisition cost is less than that of the reference (i.e., brand-name) product. PDP sponsors must also establish specific cost-sharing tiers that apply lower cost-sharing requirements for such covered generic drugs and biosimilars as compared to those for brand-name products. The bill also prohibits PDP sponsors from instituting certain requirements relating to access to such covered generic drugs and biosimilars that are more restrictive than those for brand-name products (e.g., prior authorization requirements).
Elijah E. Cummings Lower Drug Costs Now Act This bill establishes several programs and requirements relating to the prices of prescription drugs. In particular, the bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs (current law prohibits HHS from doing so). Specifically, HHS must negotiate maximum prices for single-source, brand-name drugs that lack certain generics and that are among either the 125 drugs that account for the greatest national spending or the 125 drugs that account for the greatest Medicare spending. HHS must negotiate the prices of at least 25 such drugs for 2024 and of at least 50 such drugs thereafter and must also negotiate prices for certain newly approved drugs and for insulin products. The negotiated prices must be offered under Medicare and may also be offered under private health insurance unless the insurer opts out. The negotiated maximum price may not exceed (1) 120% of the average price in Australia, Canada, France, Germany, Japan, and the United Kingdom; or (2) if such information is not available, 85% of the U.S. average manufacturer price. Drug manufacturers that fail to comply with the bill's negotiation requirements are subject to civil and tax penalties. The bill also makes a series of additional changes to Medicare prescription drug coverage and pricing, including by (1) requiring drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs that cost $100 or more and for which the average manufacturer price increases faster than inflation, and (2) capping annual out-of-pocket spending under the Medicare prescription drug benefit. The bill also requires drug manufacturers to report specified information for certain high-cost drugs, and it provides funds for opioid epidemic initiatives and biomedical research.
Sets forth the rule for consideration of the joint resolution (H.J. Res. 11) proposing an amendment to the Constitution of the United States to require that the Supreme Court of the United States be composed of nine justices.
Pharmaceutical Supply Chain Defense and Enhancement Act This bill requires the Department of Health and Human Services (HHS) to enter into contracts with U.S. entities to manufacture certain critical drugs within the United States. The Food and Drug Administration (FDA) must periodically report to Congress a list of drugs that are critical to public health or national security. The Biomedical Advanced Research and Development Authority within HHS must enter into contracts for qualified U.S. entities to manufacture in the United States the drugs on this list (and ingredients for such drugs). Such contracts must impose certain conditions, such as requiring the manufacturing entity to (1) develop and maintain a redundancy risk management and continuity of business plan, and (2) commit to selling the drugs and ingredients manufactured under the contract at reasonable prices. Beginning in FY2025, certain federal agencies, including the Department of Defense and the Bureau of Prisons, must give priority, in procuring drugs on the FDA critical drugs list, to those that are manufactured in the United States and of high quality. The bill also requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report must address, among other topics, the effect of the industry's reliance on foreign manufacturing.
Extending Tribal Broadband Priority Act of 2021 This bill requires the Federal Communications Commission (FCC) to, within 30 days, establish a new tribal priority window for the 2.5 gigahertz band, through which tribes in rural areas may apply for unassigned spectrum. The new window is subject to the same terms and conditions as the tribal priority window that was adopted by the FCC on July 10, 2019, and that closed on September 2, 2020.
Nuclear Weapons Abolition and Economic and Energy Conversion Act of 2021 This bill directs the U.S. government to sign and ratify the United Nations Treaty on the Prohibition of Nuclear Weapons or a similar international agreement that calls for the elimination of all nuclear weapons in every country. The government shall (1) redirect resources currently used in nuclear weapons programs toward building an ecologically beneficial peace economy and addressing human and infrastructure needs, and (2) actively promote policies to induce all other countries to take similar actions.
Abortion Providers Loan Elimination Act This bill makes abortion providers ineligible to receive a loan under the Paycheck Protection Program, which was established to support small businesses in response to COVID-19. This prohibition shall not apply to hospitals or entities that exclusively provide abortions (1) where the pregnancy is the result of rape or incest, or (2) where the pregnancy endangers the life of the mother. The Inspector General of the Small Business Administration must report on the number of paycheck protection loans made to the Planned Parenthood Federation of America and to other abortion providers.
